Y

YungShin Global Holding Corp
TWSE:3705

Watchlist Manager
YungShin Global Holding Corp
TWSE:3705
Watchlist
Price: 54.3 TWD 0.93%
Market Cap: 14.5B TWD
Have any thoughts about
YungShin Global Holding Corp?
Write Note

YungShin Global Holding Corp
Accounts Receivables

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

YungShin Global Holding Corp
Accounts Receivables Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Accounts Receivables CAGR 3Y CAGR 5Y CAGR 10Y
Y
YungShin Global Holding Corp
TWSE:3705
Accounts Receivables
NT$1.4B
CAGR 3-Years
-3%
CAGR 5-Years
-3%
CAGR 10-Years
2%
Formosa Laboratories Inc
TWSE:4746
Accounts Receivables
NT$936.6m
CAGR 3-Years
13%
CAGR 5-Years
1%
CAGR 10-Years
4%
ScinoPharm Taiwan Ltd
TWSE:1789
Accounts Receivables
NT$478.6m
CAGR 3-Years
19%
CAGR 5-Years
2%
CAGR 10-Years
-6%
S
SCI Pharmtech Inc
TWSE:4119
Accounts Receivables
NT$334.3m
CAGR 3-Years
28%
CAGR 5-Years
-7%
CAGR 10-Years
5%
Lotus Pharmaceutical Co Ltd
TWSE:1795
Accounts Receivables
NT$7.2B
CAGR 3-Years
28%
CAGR 5-Years
33%
CAGR 10-Years
21%
Standard Chem & Pharm Co Ltd
TWSE:1720
Accounts Receivables
NT$1.2B
CAGR 3-Years
15%
CAGR 5-Years
9%
CAGR 10-Years
8%
No Stocks Found

YungShin Global Holding Corp
Glance View

Market Cap
14.5B TWD
Industry
Pharmaceuticals

YungShin Global Holding Corp. engages in resources integration and business development. The company is headquartered in Taipei City, Taipei. The company went IPO on 2011-01-03. The firm mainly invests in the manufacturing and trading of various medicines, animal medicines, Chinese medicines, health foods, chemicals, cosmetics, soaps, medicated soaps, various detergents, spices, feeds, diagnostic equipment and reagents. The firm also invests in the sales of pharmaceuticals, pharmaceutical raw materials and health food raw materials, as well as the production and sales of chemical drugs and feed additives and other animal products. The main products are antibiotic injection items, various aqueous solutions for medicine and oral tablets of antibiotics, veterinary drug products, medicated feed additives and non-medicated feed additives and others.

Intrinsic Value
72.43 TWD
Undervaluation 25%
Intrinsic Value
Price
Y

See Also

What is YungShin Global Holding Corp's Accounts Receivables?
Accounts Receivables
1.4B TWD

Based on the financial report for Sep 30, 2024, YungShin Global Holding Corp's Accounts Receivables amounts to 1.4B TWD.

What is YungShin Global Holding Corp's Accounts Receivables growth rate?
Accounts Receivables CAGR 10Y
2%

Over the last year, the Accounts Receivables growth was 11%. The average annual Accounts Receivables growth rates for YungShin Global Holding Corp have been -3% over the past three years , -3% over the past five years , and 2% over the past ten years .

Back to Top